Clinical trial Recruiting at 1 site Observational Ages 18 and up

Lung cancer risk from CT scans in people with a family history

Official title: LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B

Run by Massachusetts General Hospital · NCT07600801 · Data updated 2026-11-12

Researchers test a deep learning model called Sybil to see if chest CT images can predict future lung cancer risk in people who have relatives with the disease.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2250 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedJune 17, 2026
Main results expectedDecember 31, 2033
Study endsDecember 31, 2035
Registry record updatedAugust 25, 2026
Trial IDNCT07600801 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with at least one first-degree or two second-degree relatives diagnosed with lung cancer who can provide at least one prior chest CT image.

Probably not a fit

Individuals without available prior CT images or without a qualifying family history may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study enrolling adults with a family history of lung cancer. Participants provide a questionnaire about medical history and exposures and share chest CT images from previous scans. The study uses an image-based AI model (Sybil) to estimate each person’s future risk of developing lung cancer based on those CT images. The goal is to determine how well Sybil predicts risk in this specific, higher-risk population. About 2,250 participants are planned to enroll at Massachusetts General Hospital.

Why it matters

Potential benefit: If successful, the approach could help identify high-risk individuals for closer monitoring or early detection strategies.

How similar studies have gone: Previous work with similar imaging-based AI approaches has shown promise in risk prediction, but applicability to people with a family history has not been fully established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥18 years of age
* Positive family history of lung cancer (defined as):

  * Has ≥1 first-degree relative OR
  * Has ≥2 second-degree relatives with a diagnosis of non-small cell lung cancer or small cell lung cancer (NB: a first-degree relative = parent, sibling, or child, a second-degree relative = grandparent, blood-related aunt or uncle, grandchild, blood-related niece or nephew, half-sibling)
* Willing to provide images from at least one previously obtained CT Chest scan, if available.

Exclusion Criteria:

\- None

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Allison Chang, MD — Massachusetts General Hospital
  • Study coordinator: Allison Chang, MD
  • Email: aechang@mgb.org
  • Phone: 617-724-4000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.